FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:CDH1-ATP1A1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: CDH1-ATP1A1
FusionPDB ID: 15028
FusionGDB2.0 ID: 15028
HgeneTgene
Gene symbol

CDH1

ATP1A1

Gene ID

51343

480

Gene namefizzy and cell division cycle 20 related 1ATPase Na+/K+ transporting subunit alpha 4
SynonymsCDC20C|CDH1|FZR|FZR2|HCDH|HCDH1ATP1A1|ATP1AL2
Cytomap

19p13.3

1q23.2

Type of geneprotein-codingprotein-coding
Descriptionfizzy-related protein homologCDC20 homolog 1CDC20-like 1bCDC20-like protein 1cdh1/Hct1 homologfizzy/cell division cycle 20 related 1sodium/potassium-transporting ATPase subunit alpha-4ATPase, Na+/K+ transporting, alpha 4 polypeptideATPase, Na+/K+ transporting, alpha polypeptide-like 2Na(+)/K(+) ATPase alpha-4 subunitNa+/K+ ATPase 4Na+/K+ ATPase, alpha-D polypeptideNa,K-ATPase su
Modification date2020031320200313
UniProtAcc

Q9H159

Main function of 5'-partner protein: FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types.

Q5TC04

Main function of 5'-partner protein:
Ensembl transtripts involved in fusion geneENST idsENST00000562836, ENST00000261769, 
ENST00000422392, 
ENST00000295598, 
ENST00000369496, ENST00000537345, 
ENST00000491156, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score21 X 16 X 8=268819 X 23 X 5=2185
# samples 2924
** MAII scorelog2(29/2688*10)=-3.21240833276383
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(24/2185*10)=-3.18652696877944
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: CDH1 [Title/Abstract] AND ATP1A1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: CDH1 [Title/Abstract] AND ATP1A1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)CDH1(68846059)-ATP1A1(116942055), # samples:1
Anticipated loss of major functional domain due to fusion event.CDH1-ATP1A1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CDH1-ATP1A1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CDH1-ATP1A1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
CDH1-ATP1A1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneCDH1

GO:0031145

anaphase-promoting complex-dependent catabolic process

18662541|21596315

HgeneCDH1

GO:0072425

signal transduction involved in G2 DNA damage checkpoint

18662541

HgeneCDH1

GO:1904668

positive regulation of ubiquitin protein ligase activity

11459826

TgeneATP1A1

GO:0030317

flagellated sperm motility

12112599

TgeneATP1A1

GO:0030641

regulation of cellular pH

12112599



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:68846059/chr1:116942055)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across CDH1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ATP1A1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000261769CDH1chr1668846059+ENST00000295598ATP1A1chr1116942055+22461306411234397
ENST00000261769CDH1chr1668846059+ENST00000537345ATP1A1chr1116942055+22441306411234397
ENST00000261769CDH1chr1668846059+ENST00000369496ATP1A1chr1116942055+22441306411234397
ENST00000422392CDH1chr1668846059+ENST00000295598ATP1A1chr1116942055+21191179641107347
ENST00000422392CDH1chr1668846059+ENST00000537345ATP1A1chr1116942055+21171179641107347
ENST00000422392CDH1chr1668846059+ENST00000369496ATP1A1chr1116942055+21171179641107347

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000261769ENST00000295598CDH1chr1668846059+ATP1A1chr1116942055+0.0009166290.9990834
ENST00000261769ENST00000537345CDH1chr1668846059+ATP1A1chr1116942055+0.0009180630.99908197
ENST00000261769ENST00000369496CDH1chr1668846059+ATP1A1chr1116942055+0.0009180630.99908197
ENST00000422392ENST00000295598CDH1chr1668846059+ATP1A1chr1116942055+0.0007245460.9992755
ENST00000422392ENST00000537345CDH1chr1668846059+ATP1A1chr1116942055+0.0007238750.9992761
ENST00000422392ENST00000369496CDH1chr1668846059+ATP1A1chr1116942055+0.0007238750.9992761

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for CDH1-ATP1A1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide

Top

Potential FusionNeoAntigen Information of CDH1-ATP1A1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Potential FusionNeoAntigen Information of CDH1-ATP1A1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of CDH1-ATP1A1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of CDH1-ATP1A1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score

Top

Vaccine Design for the FusionNeoAntigens of CDH1-ATP1A1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of CDH1-ATP1A1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample

Top

Potential target of CAR-T therapy development for CDH1-ATP1A1

check button Predicted 3D structure. We used RoseTTAFold.
91_CDH1-ATP1A1_bf4ad_pred.pdb


check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneATP1A1chr16:68846059chr1:116942055ENST00000295598023132_15201024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000295598023289_30801024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000295598023321_33801024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000295598023773_79201024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000295598023803_82301024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000295598023844_86601024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST0000029559802388_10801024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000295598023919_93801024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000295598023952_97001024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000295598023986_100601024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000369496023132_1520993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000369496023289_3080993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000369496023321_3380993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000369496023773_7920993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000369496023803_8230993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000369496023844_8660993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST0000036949602388_1080993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000369496023919_9380993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000369496023952_9700993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000369496023986_10060993.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000537345023132_15201024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000537345023289_30801024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000537345023321_33801024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000537345023773_79201024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000537345023803_82301024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000537345023844_86601024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST0000053734502388_10801024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000537345023919_93801024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000537345023952_97001024.0TransmembraneHelical
TgeneATP1A1chr16:68846059chr1:116942055ENST00000537345023986_100601024.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result
CDH1chr1668846059ENST00000261769ATP1A1chr1116942055ENST00000295598
CDH1chr1668846059ENST00000422392ATP1A1chr1116942055ENST00000295598

Top

Related Drugs to CDH1-ATP1A1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to CDH1-ATP1A1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource